Clinical Trials Directory

Trials / Unknown

UnknownNCT03447093

The Oral Microbiota is Associated With Autoimmune Thyroiditis

The Oral Microbiota in Autoimmune Thyroiditis is Distinctive And Predictive

Status
Unknown
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
First Affiliated Hospital of Harbin Medical University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Autoimmune thyroiditis (AITD) mainly includes Hashimoto's thyroiditis (HT) and Grave's disease (GD). Studies have shown that autoimmune thyroiditis is closely related to microbial disorders such as autoimmune thyroiditis However, there is no report on the relationship between oral microecology and autoimmune thyroiditis. Therefore, our group will study the correlation between oral microbiota and AITD.

Detailed description

Autoimmune thyroiditis (AITD) mainly includes Hashimoto's thyroiditis (HT) and Grave's disease (GD). Studies have shown that autoimmune thyroiditis is closely related to microbiological disorders. Intestinal microelements Both ecology and oral microecology belong to the category of microorganisms. It has been reported in the literature that intestinal microecology occurs disorder of autoimmune thyroiditis. However, there is no report on the correlation between oral microecology and autoimmune thyroiditis. When oral microbe flora When the immune system is disrupted, the immune balance is broken, the immune system is over-active, and the autoimmune disease (AID) is lost to the autoantigens and non-pathogenic commensal microbial flora antigens, including rheumatoid arthritis, Sjogren's syndrome, systemic lupus erythematosus, inflammatory bowel disease, and allergic diseases. However, the association between oral microbial flora and AITD remains unclear. . Therefore, the research group will carry out the correlation between oral microbial flora and AITD.

Conditions

Interventions

TypeNameDescription
DRUGMethimazole PillPatients who developed GD received methimazole treatment
DRUGPropylthiouracil PillPatients who developed GD received propylthiouracil treatment

Timeline

Start date
2017-12-23
Primary completion
2019-12-01
Completion
2021-12-01
First posted
2018-02-27
Last updated
2018-02-27

Locations

1 site across 1 country: China

Regulatory

Source: ClinicalTrials.gov record NCT03447093. Inclusion in this directory is not an endorsement.